Table 2.
The estimated values of for COVID-19 in prior studies.
| Country | Reference | |
|---|---|---|
| 5.25 | Brazil | Crokidakis (2020a, b) |
| 3.28 (average of estimations in 12 studies) | China | Liu et al. (2020) |
| European Union | Linka et al. (2020) | |
| 4.5 | Global (across many nations) | Katul et al. (2020) |
| 2.56 | India | Rai et al. (2020) |
| 2.7 (95%CI, 2.1–3.4) | Iran | Khosravi et al. (2020) |
| 2.6 (95%CI, 2.3–2.9) or 3.3 (95%CI, 3.0–3.6) | Italy | Zhuang et al. (2020) |
| 1.954 (95%CI, 1.851–2.025) | Japan | Chen et al. (2020) |
| 1.49 (95%CI, 1.30–1.70) | Japan | Kobayashi et al. (2020) |
| 2.86 (95%CI, 2.73–2.97) | Japan | Kurita et al. (2020) |
| 2.50 (95%CI, 2.43–2.55) | Japan | Sugishita et al. (2020) |
| 2.6 (95%CI, 2.3–2.9) or 3.2 (95%CI, 2.9–3.5) | Republic of Korea | Zhuang et al. (2020) |
| 4.234 (95%CI, 3.764–4.7) | Russia | Nabi (2020) |
| 4.02 (95%CI, 3.69–5.15) | USA | Gunzler (2020) |